Arch Pharmalabs Ltd


BSE: 524729 | NSE: NA | ISIN: INE182F01017 
Market Cap: [Rs.Cr.] 19 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Board Meet

29-Jun-06 
Accounts 
30-Jan-06 
Quarterly Results 
21-Dec-05 
Board has passed the resolution, for the allotment of 1,00,00,000 7.5% Redeemable Preference Shares (RPSs) of the face value of Rs 10/- each at par, to Arch Financial Services (Bombay) Pvt Ltd., aggregating to Rs 10,00,00,000/-, in pursuance to approval of the shareholders for the said allotment at the Annual General Meeting of the Company held on December 09, 2005. (As per Board Decision BSE Bulletin dated on 27/12/2005) 
28-Jul-05 
Quarterly Results 
30-Apr-05 
Quarterly Results 

AGM

09-Dec-05
AGM 09/12/2005 The company has informed that the members at the 12th Annual General Meeting (AGM) of the Company held on December 09, 2005, inter alia, have passed the following resolutions: 1. Adoption of the Audited Statement of Accounts together with Reports of Directors and Auditors for the yearended March 31, 2005. 2. Declaration of dividend @ 10% on the Cumulative Convertible Preference Shares. 3. Re-appointment of Mr. Rashmikant Choksey, Mr. Sudhir Ghate and Dr. Shantilal Jain on the Board of Director of the Company. 4. Re-appointment of M/s. Nayak & Rane, Chartered Accountants, as the Statutory Auditors of the Company. 5. Reclassification of the authorised share capital of the Company and consequential alteration in the Memorandum and Articles of Association of the Company. 6. Issue and allotment of 1,00,00,000 7.5% Redeemable Preference Shares to Arch Financial Services (Bombay) Pvt Ltd redeemable within a period of 36 months. 7. Resolution No. 10 in the Notice for the Annual General Meeting for issue and allotment of 23,90,000 equity shares of the Company of Rs 10/- each and at a premium of Rs 110/- per share, to Olympus Medica Holdings Ltd, Mauritius was declared as cancelled by the Chairman at the meeting. 8. Approval of delisting of the shares of the Company from the Bombay Stock Exchange Ltd, the Hyderabad Stock Exchange Ltd and Madras Stock Exchange Ltd. (As per BSE Bulletin dated on 13/12/2005) Board has passed the resolution, for the allotment of 1,00,00,000 7.5% Redeemable Preference Shares (RPSs) of the face value of Rs 10/- each at par, to Arch Financial Services (Bombay) Pvt Ltd., aggregating to Rs 10,00,00,000/-, in pursuance to approval of the shareholders for the said allotment at the Annual General Meeting of the Company held on December 09, 2005. (As per BSE Bulletin dated on 27/12/2005) 
30-Sep-04
AGM 30/09/2004 
28-Oct-03
The company has informed that the resolution for effecting restructuring of the Capital, as a part of the Sanctioned Scheme of reverse of merger has been duly passed at the AGM held on 28-10-2003.  

EGM

22-Mar-05
EGM 22/03/2005 To Authorise the Board to offer and issue for cash on a preferential basis the following securities on such terms as may be deemed appropriate by the Board upto: a) 2,40,000 (Two Lakh Forty Thousand only) Equity Shares of the Company, of the face value of Rs 10/- each and at a premium of Rs 80/- per share, to SARA Fund Trustee Company Ltd - A/c SARA Fund aggregating to Rs 2,16,00,000 (Rupees Two Crores and Sixteen Lakhs only). b) 40,000 (Forty Thousand only) Equity Shares of the Company, of the face value of Rs 10/- each and at a premium of Rs 80/- per share, to The Trustees, IVC Employees Welfare Trust aggregating to Rs 36,00,000 (Rupees Thirty six Lakhs only). c) 3,00,000 (Three lakhs only) Equity Shares of the Company, of the face value of Rs 10/- each and at a premium of Rs 102.50/- per share, aggregating to Rs 3,37,50,000 (Rupees Three Crores Thirty seven lakhs and Fifty Thousand only) to the following entities belonging to the promoter group of the Company namely, 1. Arch Financial Services (Bom) Pvt Ltd - 1,50,000 Equity Shares, and 2. Arch Phytochemicals Pvt Ltd - 1,50,000 Equity Shares d) 1,58,40,000 (One Crore Fifty Eight Lakhs and Forty Thousand only) Optionally Unsecured Fully Convertible Debentures of the Company, of the face value of Rs 10/- each against Debentures in Arch Pharmachem Ltd held by "IL&FS Trust Company Ltd A/c IL&FS Pvt Equity Trust - Leverage India Fund", aggregating to Rs 15,84,00,000/- (Rupees Fifteen Crores and Eighty Four Lakhs only). where the Debenture holder shall have the option of converting the Debentures into 17,60,000 (Seventeen Lakh Sixty thousand only) Equity Shares of the Company of the face value of Rs 10/- each at a premium of Rs 80/- per share on the basis of certain terms & conditions. The company has informed that at the EGM held on 22.03.05 the shareholders approved as follows: 1. Preferential issue of 240000 equity shares of Rs.10/- each at a premium of Rs.80/- per share to SARA Fund TrusteeCo. Ltd. - A/c SARA Fund on a private placement basis. 2. Preferential issue of 40000 equity shares of Rs.10/- each at a premium of Rs.80/- per share to the Trustees, IVC Employees Welface Trust, on a private placement basis. 3. Preferential issue of 300000 equity share of Rs.10/- each at a premium ofRs.102.50 per share to the promoters / directors of the company. 4. Preferenital issue of 15840000 Optionally Unsecured Fully convertible Debentures of Rs.10/- each at par in Arch Pharmalabs Ltd. convertible into 1760000equity shares of Rs.10/- each at a premium of Rs.80/- per share against debentures in the company held by IL&FS Trust Company Ltd. A/c IL&FS Private Equity Trust - Leverage India Fund. (As per BSE Bulletin dated on 22/03/2005) 
23-Feb-04
EGM 23/02/2004 To increase or reduce the capital of the company.  
27-Jun-03
EGM 27/06/2003 - To consider the Scheme of Arrangement between the company and its members for the purpose of amalgamation / merger of ARCH COMMERZ PRIVATE LTD with the company subject to approval of BIFR.  

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 53,021.18 18.09 7.60 12.61 39.3 49.4 0.07
Divi's Lab. 19,574.65 24.72 6.45 14.99 25.9 32.9 0.02
Jubilant Life 2,992.45 13.15 1.73 15.32 4.2 7.0 1.52
Shilpa Medicare 2,015.25 24.93 4.13 9.81 14.9 14.9 0.25
Vinati Organics 1,724.54 20.01 5.56 5.75 32.1 27.2 0.96
Suven Life Scie. 1,358.38 9.76 5.14 3.88 68.8 67.7 0.50
Granules India 1,287.25 14.53 3.74 5.09 11.7 13.3 0.76
Marksans Pharma 1,286.90 23.19 8.79 4.97 41.9 19.5 0.00
Dishman Pharma. 1,164.90 13.43 1.46 5.90 9.1 11.6 0.72
Sequent Scien. 1,047.89 0.00 26.08 0.00 0.0 0.0 2.06
Hikal 1,004.65 15.68 2.52 8.61 -2.5 5.0 1.57
Shasun Pharma. 950.56 27.83 2.69 8.58 11.7 9.0 1.56
Aarti Drugs 755.00 12.97 3.01 4.35 26.9 21.9 1.39
Nectar Lifesci. 616.83 9.93 0.67 4.00 10.4 12.8 1.16
Orchid Chemicals 527.32 0.00 1.08 16.79 0.0 0.0 3.31

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Ajit A Kamath , Chairman & Managing Director  

T Mallikarjuna Reddy , Vice Chairman  

Rajendra P Kaimal , Executive Director  

Manoj T Jain , Deputy Managing Director  


Company Head Office / Quarters:
541/A ARCH House,
Marol Maroshi Road Marol,
Mumbai,
Maharashtra-400072
Phone :
Fax :
E-mail :
Web : http://www.archpharmalabs.com
Registrars:

No data found

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Aug-2014
M T W T F S S
28 29 30 31 01 02 03
IPO
listIssue Open : Vishal Fabrics
Economic Events
list Construction Spending (MoM)
list ISM Manufacturing
Results
list Berger Paints | Berger Paints | Cummins India | Cummins India